Pulmonary: Page 15

European Commission approves new first-line treatment for NSCLC
Lazertinib-amivantamab combination therapy shows success compared to current standard of care.
January 29, 2025
Cancer survivor and friend outside
Hyperuricemia could contribute to PAH
Analysis suggests high uric acid levels could be an important risk factor for pulmonary arterial hypertension.
January 29, 2025
Blood sampling tube for uric acid analysis.
Pulse check: Newly proposed FDA guidance
Updated recommendations aim to improve performance of pulse oximeters for all people.
January 17, 2025
African American person using pulse oximeter
Sponsored
Pulmonary drug market forecast
Ascend Media
Review analysis, trends and predictions for pulmonary drug delivery systems, 2026 to 2035.
July 21, 2026
Pulmonary drug market forecast
Aspartate’s surprising role in driving cancer
Discovery opens door to new therapeutic interventions for lung metastases.
January 17, 2025
Malignant Cancerous Growth as growing dividing tumor cells and Malignancy disease spreading metastasized on an organ inside the human body as a 3D illustration.
New lung scan shows treatment effects in real time
Test could help identify lung function decline sooner.
January 7, 2025
Lung function MRI showing problem areas (measurement levels of dysfunction) in lung transplant recipients.
A novel benefit of cough syrup
Common ingredient could help treat lung fibrosis.
January 6, 2025
Lung fibrosis occurs after accumulation of scar tissue in the lung. A mouse lung with scarring tissue (left image) was reduced after treatment with dextromethorphan (right image).
Sponsored
Pulmonary fibrosis insight
Ascend Media
The 2026 report provides global pipeline therapies in various clinical trial stages.
August 10, 2026
Pulmonary fibrosis insight
Deupirfenidone phase 2b trial achievements
The potential IPF therapy successfully slowed the rate of lung function decline compared to placebo and standard-of-care treatment.
January 6, 2025
Senior Hispanic man testing breathing function
Potential breakthrough for treating lung cancer
New technology delivers nanomedicines through manufactured gas bubbles.
January 2, 2025
Nanobot seeking and destroying cancer cells or viruses inside human organs.
Evaluation of zelicapavir for pediatric RSV
Phase 2 results demonstrate favorable safety and efficacy endpoints.
December 9, 2024
Female adult helps small child with RSV use nebulizer.
Sponsored
Pulmonary fibrosis insight
Ascend Media
The 2026 report provides global pipeline therapies in various clinical trial stages.
August 10, 2026
Pulmonary fibrosis insight
FDA approves new drug for difficult-to-treat NRG1+ NSCLC
Bizengri becomes first and only therapy for patients with non-small cell lung cancer with specific driver.
December 6, 2024
Hospital, holding hands and bed with doctor, support and care together
Robot performs first-ever double lung transplant
NYU Langone Health also first to use robotic system at every stage of implantation.
December 3, 2024
Double lung transplant patient
Long COVID’s impact on lung, brain function
Researchers find correlation in impaired cognition and reduced pulmonary gas exchange.
November 26, 2024
Asian man wearing a mask has a headache and has difficulty breathing with long covid
Previous Page
Page 15 of 29
Next Page
Most Popular
Is there a ‘window of opportunity’ for biologic treatment in severe asthma?
FDA approves study of inhaled stem cell therapy for COPD
Common cold: There may be a vaccine for that
Semaglutide significantly lowers asthma, COPD attacks
Childhood pollution exposure linked to COPD
Novel inhaled treatment for COPD shows promise in clinical trial